Exodus Point Capital Management, LP Alnylam Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 18,658 shares of ALNY stock, worth $4.62 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
18,658Holding current value
$4.62 Million% of portfolio
0.02%Shares
12 transactions
Others Institutions Holding ALNY
# of Institutions
585Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.17 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$2.97 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.23 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.79 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.64 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.5B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...